THE GREENBRIER COMPANIES, INC. (GBX): what the price requires
The current priced-in claim for THE GREENBRIER COMPANIES, INC. (GBX) is temporarily suppressed because the live engine record is unavailable. The dated report remains a snapshot, not a current market read.
Generated: 2026-07-14 · Exported: 2026-07-17 · Source: https://boothcheck.com/report/GBX
Headline
| Field | Value |
|---|---|
| Ticker | GBX |
| Company | THE GREENBRIER COMPANIES, INC. |
| Current price | $48.44/sh |
| Composition | Manufacturing 92% / Leasing & Fleet Management 8% |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin needed | 4.5% |
| Operating margin today | 9.1% |
| Margin compression implied | -4.6pp |
| Multiple paid | 11x operating income |
The operating-margin requirement is derived from the framework's value band at year 12, a separately labeled basis from the headline growth/duration solve.
The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.
Solve inputs: computed at a 7% cost of capital with 4% terminal growth over a 5-year stage (computed at the 7% minimum rate; the CAPM rate 5.1% sits below it).
Reconcile: at the x-ray's 9.3% required return this reads ~-2.6%/yr; the models below use their own rates.
How unusual the bet is: within-range
| Reference | Value |
|---|---|
| vs own history | -0.54σ |
| cohort percentile (of 225 peers) | 8 |
| implied end-window share | 0% |
Valuation X-Ray
The price is supported by asset-based and earnings-power and relative-multiple value, while growth-DCF lands below the price. A value/asset-supported name, not a pure growth bet.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 0.95x | 5 | justifies |
| Earnings | 1.23x | 5 | expensive |
| Relative | 0.59x | 3 | justifies |
| Growth | 1.83x | 4 | expensive |
Families that justify the price: Asset, Earnings, Relative Families that call it expensive: Growth
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 6.4%); the inversion above states its own rate.
Per-Model Detail (n=17)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $47.06 | 1.03x | yes | FCF base $0.2B, growth -10% (input: historical growth), terminal g 0.5%, WACC 6.4%, 5yr projection |
| DCF Exit Multiple | Growth | $58.65 | 0.83x | yes | Exit EV/EBITDA: 6.8x / 8.8x / 10.8x (bear / base = today's held flat / bull), 5yr |
| Relative Valuation | Relative | $82.11 | 0.59x | yes | P/E 18x (static sector reference · 2026-04), scenarios: 15.3x / 18.0x / 20.7x (bear / base = reference held flat / bull), EV/EBITDA 12x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | $17.97 | 2.70x | yes | Stage 1: -16% for 5yr, Stage 2: 3.5% perpetual |
| Simple Excess Return | Asset | $50.52 | 0.96x | yes | BV/sh $49.31, ROE (TTM) 9.5%, ke 9.3% |
| Two-Stage Excess Return | Asset | $51.13 | 0.95x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $18.40 | 2.63x | yes | Rev $2.9B, growth -15% (input: historical growth; tapered), Terminal P/S: 0.5x / 0.5x / 0.6x (bear / base = today's held flat / bull, cap 8x) |
| Growth-Adjusted P/E | Relative | — | — | no | — |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $46.54 | 1.04x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $0.23B × (1−21%) / WACC 6.4% → EPV (no growth) |
| Residual Income | Asset | $51.24 | 0.95x | yes | BV $49.31 + 5yr PV of (ROE (TTM) 9.5% − Kₑ 9.3%) × BV; BV grows 6.2%/yr |
| Graham Number | Asset | $72.05 | 0.67x | yes | √(22.5 × EPS $4.68 × BVPS $49.31) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $79.98 | 0.61x | yes | EBITDA $0.31B × sector EV/EBITDA 12.0x |
| FCF Yield | Earnings | $39.42 | 1.23x | yes | FCF $230.5M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | $33.22 | 1.46x | yes | SBC-adj FCF $0.21B (FCF $0.23B − SBC $0.02B) capitalized at Kₑ |
| Ben Graham Formula | Earnings | $3.92 | 12.36x | yes | EPS $4.68 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | $5.43 | 8.92x | yes | BV $49.31 × (ROIC 0.7% / WACC 6.4%) |
| P/Sales Sector | Relative | $228.14 | 0.21x | yes | Revenue $2.90B × sector P/S 2.5x |
| PEG Fair Value | Relative | — | — | no | — |
| Earnings Yield | Earnings | $50.59 | 0.96x | yes | EPS $4.68 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net debt | $1.2b |
| Net debt / NOPAT (after-tax) | 5.99x |
| Net debt / operating income (pre-tax) | 4.73x |
| Share count CAGR (buyback) | -2.0% |
| Burning cash | no |
Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.
Bullet Takeaways
- Greenbrier trades almost exactly at book value ($49.70 price against $49.31 book), so the market pays nothing above accounting net worth for a railcar maker earning a roughly 9.5% ROE with $4.68 trailing EPS and $230 million of free cash flow.
- The order book underwrites near-term revenue (backlog 15,200 cars worth about $2.1 billion) but is shrinking, and fiscal Q2 2026 earnings fell to $0.47 from $1.14 in Q1 as deliveries dropped, the cyclical down-leg is in progress.
- The capital-allocation risk is a debt-funded lease-fleet build (gross investment rising to $300 million) into softening demand on a balance sheet already near 5x net-debt-to-operating-income; a price at book is cheap only if this is the trough.
Bull Case
The market is pricing Greenbrier as a cyclical manufacturer at the wrong point in its cycle, and the gap between that read and the fundamentals is where the opportunity sits. At $49.70 the stock trades almost exactly at its book value of $49.31 per share, which means the market is paying nothing for the franchise above its accounting net worth. For a company that designs and builds railcars, operates a growing lease fleet, and earns a trailing return on equity near 9.5%, roughly its cost of equity, a price at book implies the market expects no value creation at all going forward. The fundamentals say otherwise: Greenbrier is profitable through the down-leg, generating free cash flow over $230 million and trailing EPS of $4.68.
The order book underwrites the near-term earnings the market is discounting. The 10-K states plainly that the manufacturing backlog represents future production and is an indicator of future revenues (FY2025 10-K, accession 0001193125-25-253612). As of late February 2026 that backlog stood at 15,200 new railcars worth about $2.1 billion, a multi-quarter runway of contracted demand. Management noted that some production and deliveries are shifting into early fiscal 2027 on timing rather than weakening demand, which means the revenue is deferred, not lost.
Management is also reshaping the business toward steadier earnings and returning capital. Greenbrier is investing in its lease fleet, with gross investment projections rising to $300 million, growing the recurring leasing segment that smooths the manufacturing cycle, while reporting its highest-ever quarter-end liquidity. The share count has shrunk about 2% a year. A profitable, cash-generative cyclical trading at book value, with a $2.1 billion backlog and a growing lease book, is the kind of asset-supported name where the downside is anchored by tangible value and the upside comes when the railcar cycle turns up.
Bear Case
The capital-allocation question that should give a buyer pause is how much cash Greenbrier is committing to its lease fleet just as the manufacturing cycle softens. Gross lease-fleet investment is rising to $300 million, funded against a balance sheet that already carries gross debt near $1.76 billion and net debt near $1.24 billion, roughly 5x trailing operating income. Building a lease fleet is a sound long-term strategy, but doing it with borrowed money into a decelerating demand environment ties up capital in depreciating steel assets at a time when the order book is shrinking, from 16,300 cars worth $2.2 billion in Q1 to 15,200 cars worth $2.1 billion in Q2. If demand keeps fading, the company will have levered up to add capacity it does not need.
The earnings trajectory already shows the cycle biting. Fiscal Q2 2026 net earnings fell to $15 million ($0.47 per share) from $36 million ($1.14 per share) in Q1, and EBITDA margin slipped from 14% to 10% of revenue as deliveries dropped from 4,400 to 3,800 units. Railcar manufacturing is a notoriously feast-or-famine business: orders are lumpy, tied to freight volumes, fleet age, and customer capital budgets, and the historical revenue trend embedded in the models is negative, around minus 16%. A trough in orders can persist for several quarters, and the backlog that looks comfortable today can thin quickly if customers defer.
The valuation has no margin for a deeper downturn. The price sits at book value, but several growth-based frames already say expensive: the discounted-future-market-cap method lands near $19 on negative revenue growth, and the two-stage dividend model near $18. The asset-based frames near $50 to $51 only hold if book value is realized rather than impaired, and the ROIC-justified frame near $5 reflects a return on capital the company is barely earning. A cyclical at book value is cheap only if this is the trough; if orders keep declining and the lease-fleet build proves ill-timed, the book value itself comes under pressure and the floor gives way.
Valuation
Inverting the $49.70 price puts the embedded bet at a modest implied operating margin near 4.6% against a current margin near 8.7%, which is below where the company runs today, so the reverse model treats the price as already discounting a cyclical decline. The fair-value point sits at the price itself, reflecting how tightly the stock is anchored to its tangible value.
The model X-ray clusters around the price, which is the signature of an asset-supported cyclical. The simple and two-stage excess-return models land near $50 to $51 off a $49.31 book value with a 9.5% trailing ROE, residual income near $51, the earnings-yield method near $51, the perpetual-growth DCF near $47, and earnings-power value near $46. The blended landing across applicable methods is near $51, essentially at the market. Against those, the growth-based frames say expensive because trailing revenue growth is negative: the discounted-future-market-cap method lands near $19 and the two-stage dividend model near $18. The relative-valuation and EV/EBITDA methods land higher, near $80, on sector multiples that assume mid-cycle earnings.
The characterization is clean: the price is supported by asset-based and relative-multiple value while the growth-DCF says expensive, a value, asset-supported name rather than a growth bet. The peer set, ACA, CLH, HLMN, LII, and TKR, is industrial manufacturing and services where book value and normalized earnings are the right anchors. The investable question is whether the roughly 9.5% ROE and $4.68 trailing EPS represent a sustainable through-cycle level or a high that fades as orders decline. If book value holds and the cycle turns, a price at book is a reasonable entry; if the manufacturing downturn deepens and the levered lease-fleet build weighs on returns, the asset floor is softer than it looks. Net debt near 5x operating income means the cycle, not the multiple, is the variable that decides the outcome.
Catalysts
Greenbrier reported fiscal Q2 2026 (ended February 28) on April 7, with net earnings of $15 million ($0.47 per diluted share) and EBITDA of $61 million (10% of revenue), down from Q1's $36 million ($1.14 per share) and 14% EBITDA margin. Deliveries fell to 3,800 units from 4,400 in Q1. New railcar backlog stood at 15,200 units worth about $2.1 billion as of quarter end, down from 16,300 units worth $2.2 billion a quarter earlier. Management said some production and deliveries are shifting into early fiscal 2027 on timing rather than a change in underlying demand.
The near-term swing factors are the order rate and the lease-fleet build. Whether new orders stabilize the backlog or keep eroding is the single most important data point, since the backlog drives future revenue. The lease-fleet expansion, with gross investment rising to $300 million against the company's highest-ever quarter-end liquidity, is the strategic lever that should smooth the cycle but adds leverage if demand stays soft. North American freight volumes, railcar fleet age and replacement cycles, and customer capital budgets are the macro variables to watch, and the share count continues to shrink modestly through buybacks.
Sources: Greenbrier fiscal Q1 and Q2 2026 results (investors.gbrx.com, AOL/Motley Fool transcript, Simply Wall St, 2026); FY2025 10-K (accession 0001193125-25-253612).
Peer Cohorts (Per Segment, With Filing Citations)
Manufacturing / Leasing & Fleet Management (reported)
- TRN (TRINITY INDUSTRIES INC)
- (no filing in the citation store)
- WAB (WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORPORATION)
- (no filing in the citation store)
- ACA (Arcosa, Inc.)
- (no filing in the citation store)
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.